PharmaNutra SpA PHN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €71.20
- Day Range
- €69.80–71.90
- 52-Week Range
- €43.55–95.90
- Bid/Ask
- €69.60 / €71.70
- Shares Outstanding
- 9.58M
- Market Cap
- €672.18M
- Volume/Avg
- 8,862 / 12,619
Key Statistics
- Price/Earnings (Normalized)
- 32.35
- Price/Sales
- 4.71
- Dividend Yield (Trailing)
- 1.71%
- Dividend Yield (Forward)
- 1.71%
- Dividend Payment Schedule
- May
- Total Yield
- 1.85%
Company Profile
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, and other regions.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 140
- Website
- https://www.pharmanutra.it
Valuation
|
Metric
|
PHN
|
|---|---|
Price/Earnings (Normalized) | 32.35 |
Price/Book Value | 9.65 |
Price/Sales | 4.71 |
Price/Cash Flow | 26.27 |
Price/Earnings
PHN
Financial Strength
|
Metric
|
PHN
|
|---|---|
Quick Ratio | 1.67 |
Current Ratio | 2.05 |
Interest Coverage | 55.46 |
Quick Ratio
PHN
Profitability
|
Metric
|
PHN
|
|---|---|
Return on Assets (Normalized) | 16.90% |
Return on Equity (Normalized) | 30.04% |
Return on Invested Capital (Normalized) | 23.25% |
Return on Assets
PHN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|w#P$RH&$ | LOCK|qfc?H | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|&#k@M&F< | LOCK|R&?t | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|S$M!Jn | LOCK|@@N | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|jMp>rsc | LOCK|tfQ | $29B | |||
| Viatris Inc
VTRS
| LOCK|Y>>%h% | LOCK|vY& | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|&Tg | LOCK|CM@ | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|rB$l^Sr | LOCK|Dg | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|F@XTHb | LOCK|&NN | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|R%^dTZ | LOCK|<@!l | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|$^#>JC | LOCK|@w< | $2B |
United States